If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
NEPHROLOGY
EMJ Nephrol. 2017 Suppl 4 • europeanmedical-journal.com
INSIDE
Ophthalmology Cystinosis Forum
Morning & Afternoon Sessions
OPHTHALMOLOGY CYSTINOSIS FORUM
MORNING SESSION
This symposium took place on 5th December 2016
in Vienna, Austria
Chairpersons
Rachel J. Bishop,1 Katharina Hohenfellner,2 Hong Liang3
Speakers
Alexey Tsygin,4 Roser Torra5
1. National Eye Institute, National Institutes of Health, Washington DC, USA
2. LÄ Kindernephrologie, Klinikum Traunstein, Traunstein, Germany
3. Service III de l’hôpital des Quinze-Vingts, Equipe S12, Institut de la vision, Paris, France
4. NCZD Institute of Pediatrics, Moscow, Russia
5. Inherited Kidney Disorders, Nephrology Department, Fund
NEPHROLOGY EMJ Nephrol. 2017 Suppl 4 • europeanme
OPHTHALMOLOGY CYSTINOSIS FORUM
Cystinosis: Prevalence, Burden, Complication
basis. Within the subgroup, 5 out of 20 patients
functioning cystine transporter and are able
gaps in resources, and patients may be transferre
Ocular Complications of Cystinosis
Taking time in the early appointments to teach th
Significant improvements were also demonstrated in
OPHTHALMOLOGY CYSTINOSIS FORUM A
cystine. The patient was prescribed systemic and
Key Learning Points • Nephropathic cystinosis-r
Figure 2 removed due to copyright expiration.
the stinging upon administration limits tolerabil
Ophthalmology Case Reports Doctor Eleonora Maria
Ophthalmol. 1990;108(5):689-93. 20